Skip to main content

Peer Review reports

From: Long-term comparison of renal and metabolic outcomes after sodium–glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes

Original Submission
13 Nov 2023 Submitted Original manuscript
8 Dec 2023 Reviewed Reviewer Report
8 Jan 2024 Reviewed Reviewer Report
18 Feb 2024 Author responded Author comments - Minji Sohn
Resubmission - Version 2
18 Feb 2024 Submitted Manuscript version 2
10 Mar 2024 Reviewed Reviewer Report
25 Mar 2024 Author responded Author comments - Minji Sohn
Resubmission - Version 3
25 Mar 2024 Submitted Manuscript version 3
13 May 2024 Reviewed Reviewer Report
5 Jun 2024 Author responded Author comments - Minji Sohn
Resubmission - Version 4
5 Jun 2024 Submitted Manuscript version 4
11 Jun 2024 Author responded Author comments - Minji Sohn
Resubmission - Version 5
11 Jun 2024 Submitted Manuscript version 5
Publishing
13 Jun 2024 Editorially accepted
2 Jul 2024 Article published 10.1186/s12916-024-03483-z

You can find further information about peer review here.

Back to article page